Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Harvard Business School
Fish and Richardson
Fuji
Deloitte
Citi
Boehringer Ingelheim
McKinsey

Generated: September 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,455,557

« Back to Dashboard

Summary for Patent: 6,455,557
Title: Method of reducing somnolence in patients treated with tizanidine
Abstract:An article and method for reducing somnolence in a patient receiving tizanidine therapy. Tizanidine may be administered in the form of an immediate release multiparticulate composition at or around the time food is consumed. The composition may be packaged in a container for distribution.
Inventor(s): Pellegrini; Cara A. (San Diego, CA), Stark; Paul (Westmeath, IE)
Assignee: Elan Pharmaceuticals, Inc. (San Francisco, CA)
Application Number:09/994,837
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,455,557
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 6,455,557

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
McKesson
QuintilesIMS
AstraZeneca
Cerilliant
Merck
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.